Clinical and genetic determinants of coronary stent thrombosis in patients on dual antiplatelet therapy

被引:0
|
作者
Cayla, G. [1 ]
Hulot, J. S. [2 ]
Silvain, J. [1 ]
Pattack, A. [3 ]
Gruel, Y. [4 ]
Huerre, Y. [5 ]
Allanic, F. [2 ]
O'Connor, S. [1 ]
Montalescot, G. [1 ]
Collet, J. P. [1 ]
机构
[1] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Inst Cardiol,INSERM,CMR937, Paris, France
[2] Univ Paris 06, INSERM, UMR S956, Paris, France
[3] Univ Hosp Toulouse Rangueil Hosp, Toulouse, France
[4] Hosp Trousseau, Tours Reg Univ Hosp, Dept Cardiol, Tours, France
[5] Hosp Arnaud de Villeneuve, Montpellier, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:508 / 508
页数:1
相关论文
共 50 条
  • [41] Impact of stent type and prolonged dual antiplatelet therapy on long-term clinical outcomes in hemodialysis patients with coronary artery disease
    Asami M.
    Aoki J.
    Sato T.
    Tanimoto S.
    Watanabe M.
    Horiuchi Y.
    Furui K.
    Yasuhara K.
    Sato Y.
    Hashimoto T.
    Yachi S.
    Hara K.
    Tanabe K.
    Cardiovascular Intervention and Therapeutics, 2018, 33 (1) : 84 - 94
  • [42] Duration of dual antiplatelet therapy and clinical outcomes after drug-eluting stent implantation in patients presenting with acute coronary syndrome
    Song, P. S.
    Hahn, J. Y.
    Seo, G. W.
    Kim, D. K.
    Kim, K. H.
    Seol, S. H.
    Kim, D. I.
    Gwon, H. C.
    Jeong, M. H.
    Ryu, D. R.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1160 - 1161
  • [43] Stent thrombosis after second generation drug-eluting stent implantation and duration of dual antiplatelet therapy
    Amano, H.
    Kadota, K.
    Otsuru, S.
    Hasegawa, D.
    Habara, S.
    Tada, T.
    Tanaka, H.
    Fuku, Y.
    Goto, T.
    Mitsudo, K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 239 - 239
  • [44] Relation of Stent Thrombosis to Interruption of Dual Antiplatelet Therapy After Resolute Zotarolimus-eluting Stent Implantation
    Bhatt, Deepak L.
    Silber, Sigmund
    Windecker, Stephan
    Brar, Sandeep
    Liu, Minglei
    Chen, Xiaohua
    Kirtane, Ajay J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B144 - B144
  • [45] The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients
    Fan, Zhong-Guo
    Ding, Guo-Bin
    Li, Xiao-Bo
    Gao, Xiao-Fei
    Gao, Ya-Li
    Tian, Nai-Liang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3435 - 3448
  • [47] Genetic determinants of responsiveness to antiplatelet therapy
    Kral B.G.
    Lawal L.
    Becker L.C.
    Current Cardiovascular Risk Reports, 2008, 2 (6) : 476 - 484
  • [48] Stent thrombosis: Role of compliance and nonresponsiveness to antiplatelet therapy
    Gurbel, Paul A.
    Tantry, Udaya S.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2007, 8 : S19 - S26
  • [49] Stent thrombosis is associated with an impaired response to antiplatelet therapy
    Wenaweser, P
    Dörffler-Melly, J
    Imboden, K
    Windecker, S
    Togni, M
    Meier, B
    Haeberli, A
    Hess, OM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (11) : 1748 - 1752
  • [50] Antiplatelet therapy resistance: a risc factor for stent thrombosis
    Hoffmann, S.
    Klamroth, R.
    Orlovic, M.
    Landgraf, H.
    Andresen, D.
    EUROPEAN HEART JOURNAL, 2007, 28 : 191 - 191